Blennow K - Search Results

1

Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.

Montoliu-Gaya L, Benedet AL, Tissot C, Vrillon A, Ashton NJ, Brum WS, Lantero-Rodriguez J, Stevenson J, Nilsson J, Sauer M, Rahmouni N, Brinkmalm G, Lussier FZ, Pascoal TA, Skoog I, Kern S, Zetterberg H, Paquet C, Gobom J, Rosa-Neto P, Blennow K. Montoliu-Gaya L, et al. Among authors: blennow k. Nat Aging. 2023 Jun;3(6):661-669. doi: 10.1038/s43587-023-00405-1. Epub 2023 Apr 27. Nat Aging. 2023. PMID: 37198279 Free PMC article.

2

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.

Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L. Blennow K, et al. Neurobiol Aging. 1992 Jan-Feb;13(1):107-13. doi: 10.1016/0197-4580(92)90017-r. Neurobiol Aging. 1992. PMID: 1371850

3

Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age.

Blennow K, Skoog I, Wallin A, Wikkelsö C, Fredman P. Blennow K, et al. Eur Neurol. 1996;36(4):201-5. doi: 10.1159/000117248. Eur Neurol. 1996. PMID: 8814421

4

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, Blennow K. Skoog I, et al. Among authors: blennow k. Neurodegeneration. 1995 Dec;4(4):433-42. doi: 10.1006/neur.1995.0052. Neurodegeneration. 1995. PMID: 8846237

5

Dementia. It's getting better all the time.

Skoog I, Marcusson J, Blennow K. Skoog I, et al. Among authors: blennow k. Lancet. 1998 Dec 19-26;352 Suppl 4:SIV4. doi: 10.1016/s0140-6736(98)90266-5. Lancet. 1998. PMID: 9872151 Review. No abstract available.

6

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.

Skoog I, Davidsson P, Aevarsson O, Vanderstichele H, Vanmechelen E, Blennow K. Skoog I, et al. Among authors: blennow k. Dement Geriatr Cogn Disord. 2003;15(3):169-76. doi: 10.1159/000068478. Dement Geriatr Cogn Disord. 2003. PMID: 12584433

7

An 18-year follow-up of overweight and risk of Alzheimer disease.

Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. Gustafson D, et al. Among authors: blennow k. Arch Intern Med. 2003 Jul 14;163(13):1524-8. doi: 10.1001/archinte.163.13.1524. Arch Intern Med. 2003. PMID: 12860573

8

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Zetterberg H, Wahlund LO, Blennow K. Zetterberg H, et al. Among authors: blennow k. Neurosci Lett. 2003 Nov 27;352(1):67-9. doi: 10.1016/j.neulet.2003.08.011. Neurosci Lett. 2003. PMID: 14615052

9

Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease.

Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N, Andreasen N, Lenhard B, Brookes AJ, Pedersen NL, Blennow K, Prince JA. Johansson A, et al. Among authors: blennow k. Hum Genet. 2004 May;114(6):581-7. doi: 10.1007/s00439-004-1107-9. Epub 2004 Mar 18. Hum Genet. 2004. PMID: 15034781

10

APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

Prince JA, Zetterberg H, Andreasen N, Marcusson J, Blennow K. Prince JA, et al. Among authors: blennow k. Neurology. 2004 Jun 8;62(11):2116-8. doi: 10.1212/01.wnl.0000128088.08695.05. Neurology. 2004. PMID: 15184629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,086 results

Search Page